Desmond Kimberly L, Moosvi Firas, Stanisz Greg J
Department of Medical Biophysics, University of Toronto, Toronto, Canada.
Magn Reson Med. 2014 May;71(5):1841-53. doi: 10.1002/mrm.24822. Epub 2013 Jun 25.
To evaluate the performance of endogenous chemical exchange saturation transfer (CEST) spectra and derived maps in a longitudinal study of tumor xenografts to ascertain the role of CEST parameters in describing tumor progression and in distinguishing between tumor, muscle, and necrosis.
CEST spectra of 24 mice with tumor xenografts (20 LLC and 4 MDA) were acquired at three time-points. We employed a novel method of decomposing the CEST spectrum into a sum of four Lorentzian shapes, each with a corresponding measured amplitude, width and frequency offset. This semi-quantitative method is an improvement over techniques which simply assess the asymmetry in the spectrum for the presence of CEST, due to the fact that it is not confounded by CEST peaks on opposing sides of the direct effect. The CEST images were compared to several other commonly employed contrast mechanisms: T1 relaxation, T2 relaxation, diffusion (ADC), and magnetization transfer (MT).
Tumor spectra had distinct CEST peaks corresponding to the presence of hydrogen exchange between free water and amide, amine, and aliphatic groups. All three CEST peaks (amide, amine, and aliphatic) were larger in the tumor tissue as compared with the adjacent healthy muscle.
CEST contrast (particularly the amine peak amplitude) performed especially well in distinguishing areas of apoptosis and/or necrosis from actively progressing tumor, as validated by histology.
在肿瘤异种移植的纵向研究中评估内源性化学交换饱和转移(CEST)光谱及其衍生图谱的性能,以确定CEST参数在描述肿瘤进展以及区分肿瘤、肌肉和坏死组织方面的作用。
在三个时间点采集了24只患有肿瘤异种移植的小鼠(20只LLC和4只MDA)的CEST光谱。我们采用了一种将CEST光谱分解为四个洛伦兹形状之和的新方法,每个形状都有相应的测量幅度、宽度和频率偏移。这种半定量方法是对那些仅通过评估光谱不对称性来检测CEST存在的技术的改进,因为它不会受到直接效应相对两侧CEST峰的干扰。将CEST图像与其他几种常用的对比机制进行了比较:T1弛豫、T2弛豫、扩散(ADC)和磁化转移(MT)。
肿瘤光谱具有与游离水和酰胺、胺及脂肪族基团之间氢交换存在相对应的明显CEST峰。与相邻的健康肌肉相比,肿瘤组织中的所有三个CEST峰(酰胺、胺和脂肪族)都更大。
经组织学验证,CEST对比(特别是胺峰幅度)在区分凋亡和/或坏死区域与活跃进展的肿瘤方面表现尤为出色。